| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
THBD |
THBD, THRM: Thrombomodulin precursor |
0.36 |
Evidence |
|
| FABP3 |
FABP3, FABP11, MDGI: Fatty acid-binding protein, heart |
RRAD |
RRAD, RAD: GTP-binding protein RAD |
0.36 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
ETS2 |
ETS2: Protein C-ets-2 |
0.36 |
Evidence |
O
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
0.36 |
Evidence |
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
SCYL3 |
SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
STK11 |
STK11, LKB1, PJS: Serine/threonine-protein kinase 11 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
0.36 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
RPS6KB1 |
IPI00216132 |
0.36 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
0.36 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
F13B |
F13B: Coagulation factor XIII B chain precursor |
0.36 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
0.36 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
SCYL3 |
SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
PBK |
PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.36 |
Evidence |
|